Zoledronate as well as alendronate has been found to inhibit secretion and activity of MMP-2 and MMP-9 by tumor cells and tumor-infiltrating macrophages in mouse models of cervical cancer [19] and prostate cancer [50]. This evidence concerns the gene MMP9 and cervical carcinoma.